Filgrastim

CHEMBL1201567 Phase 4 Disetujui Protein

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

This medication is a laboratory-made version of a natural protein called granulocyte colony-stimulating factor, which stimulates the bone marrow to produce more white blood cells. It is used to reduce the risk of serious infection in patients whose immune systems have been weakened by chemotherapy or other conditions.

Area Terapeutik

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Endometriosis Non-Small Cell Lung Cancer Alzheimer's Disease Parkinson's Disease Melanoma Systemic Lupus Erythematosus Multiple Sclerosis Stroke Lymphoma Breast Cancer Prostate Cancer Colorectal Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

This medication is a laboratory-made version of a natural protein called granulocyte colony-stimulating factor, which stimulates the bone marrow to produce more white blood cells. It is used to reduce the risk of serious infection in patients whose immune systems have been weakened by chemotherapy or other conditions.

Yes, Filgrastim is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201567. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Mencari informasi yang ramah bagi pasien?

Filgrastim di PillFYI

Data Cepat

Sinonim: 9

Tautan Eksternal

ChEMBL CHEMBL1201567

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.